Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study

por Carmen Domínguez-Baleón, Jue-Sheng Ong, Clemens R. Scherzer, Miguel E. Rentería, Xianjun Dong
Publicado 2021

Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients

por Faith L. Anderson, Katharine M. von Herrmann, Angeline S. Andrew, Yuliya I. Kuras, Alison L. Young, Clemens R. Scherzer, William F. Hickey, Stephen L. Lee, Matthew C. Havrda
Publicado 2021

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI

por Young Eun Huh, Hyejung Park, Ming Sum Ruby Chiang, Idil Tuncali, Ganqiang Liu, Joseph J. Locascio, Julia Shirvan, Samantha J. Hutten, Melissa S. Rotunno, Catherine Viel, Lamya S. Shihabuddin, Bing Wang, Sergio Pablo Sardi, Clemens R. Scherzer
Publicado 2021